AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: Between 45 - 110 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects have clinical diagnosis of ischemic stroke + brain imaging to rule out hemorrhagic stroke
    2. Subjects who have a Modified Rankin Scale (MRS) score less than or equal to 4.
    3. Subjects who are able to be randomized no later than 120 days after stroke onset
    4. Subjects with Embolic stroke of undetermined source (ESUS) li>

You may not be eligible for this study if the following are true:

    1. Subjects with history of AF, AF on 12-lead ECG, or any AF of any duration during heart-rhythm monitoring
    2. Subjects who has clear indication for treatment-dose anticoagulant therapy
    3. Subjects with history of spontaneous intracranial hemorrhage.
    4. Subjects with chronic kidney disease
    5. Subjects with active hepatitis or hepatic insufficiency
    6. Subjects who have clinically significant bleeding diathesis.
    7. Subjects who have chronic anemia or thrombocytopenia
    8. Subjects who have clinically significant GI bleeding
    9. Subjects who are pregnant, lactating or sexually active without adequate birth control
    10. Subjects with known allergy or intolerance to aspirin or apixaban
    11. Considered to have a condition that precludes follow-up or safe participation

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.